Dr. هاشم العويري

Professional Profile and Career

Dr. Hashem Al-Owaidi is a distinguished leader in the field of clinical oncology, boasting over 15 years of extensive experience in managing complex solid and hematological malignancies. Having completed his medical training at elite international institutions, Dr. Al-Owaidi has consistently pioneered advanced therapeutic protocols. He currently serves as a Senior Consultant at PulseHospital, under the Eiadaty Health System, where he emphasizes evidence-based care integrated with the latest advancements in molecular biology and immuno-oncology.

Subspecialty Focus and Clinical Interests

Dr. Al-Owaidi’s clinical practice is rooted in the philosophy of Precision Medicine. By focusing on the molecular profiling of tumors, he tailors treatment plans to the unique genetic signature of each patient’s cancer. His core areas of expertise include:
1. Gastrointestinal and Colorectal Oncology.
2. Breast and Gynecological Cancers.
3. Thoracic and Lung Malignancies.
4. Targeted Immunotherapy.
5. Palliative Oncology and Symptom Management.

Procedures and Interventional Oversight

While the primary focus is medical management, Dr. Al-Owaidi provides expert guidance in multidisciplinary oncology teams, coordinating with surgeons and interventional radiologists. His clinical oversight includes:
- Tailored chemotherapy and targeted therapy administration.
- Immunotherapy regimen development.
- Image-guided diagnostic tumor biopsies.
- Post-surgical monitoring and long-term recurrence prevention strategies.

Advanced Diagnostic Technologies

Dr. Al-Owaidi utilizes Next-Generation Sequencing (NGS) to identify oncogenic mutations, allowing for the selection of highly specific molecular therapies. The facilities under his supervision employ cutting-edge diagnostic equipment, including PET-CT scanning and functional MRI, which allow for real-time monitoring of therapeutic response and tumor activity.

Patient Guidelines: Before and After Treatment

Dr. Al-Owaidi advocates for a holistic approach to cancer care, emphasizing nutrition and psychological resilience. Patients are advised to:
- Adhere strictly to the prescribed chemotherapy or immunotherapy schedules.
- Maintain transparent communication with the medical team regarding side effects.
- Engage in light, physician-approved physical activity to support immune health.

Frequently Asked Questions (FAQ)

Q: Is targeted therapy the same as traditional chemotherapy?
A: No. Traditional chemotherapy targets rapidly dividing cells, while targeted therapy focuses on specific proteins or genetic mutations within cancer cells, significantly reducing toxicity to healthy tissues.
Q: What is the prognosis for advanced-stage cancer patients?
A: With the recent revolution in immunotherapy and molecular diagnostics, many advanced cancers that were previously considered untreatable are now being managed effectively as chronic conditions, significantly improving survival rates and quality of life.